Go back to News
NEWS
GA_P advises Impact Partners on Top Doctors Series B financing round
14 October, 2021
Gómez-Acebo & Pombo has advised Impact Partners on its investment in Top Doctors. The Series B financing round, led by Impact Partners and in which the Institut Català de Finances (ICF) also participated, amounted to €11.2 million.
Top Doctors is a startup that offers a digital tool that allows users to access more than 90,000 experts in 50 medical specialties, while providing healthcare professionals with telemedicine solutions, online presence and brand image. The company expects to close the year with a turnover of 16 million euros, 30% more than in 2020. The capital increase will allow the company to consolidate its medical platform in the countries where it already operates in Europe, Latin America and the Middle East.
The GA_P team was formed by Álvaro Mateo and Rocío García de Oteyza, partner and associate in the Corporate area.
See complete article in CincoDías
Top Doctors is a startup that offers a digital tool that allows users to access more than 90,000 experts in 50 medical specialties, while providing healthcare professionals with telemedicine solutions, online presence and brand image. The company expects to close the year with a turnover of 16 million euros, 30% more than in 2020. The capital increase will allow the company to consolidate its medical platform in the countries where it already operates in Europe, Latin America and the Middle East.
The GA_P team was formed by Álvaro Mateo and Rocío García de Oteyza, partner and associate in the Corporate area.
See complete article in CincoDías
Press contact
Director of Business Development, Marketing and Communications
Director of Business Development, Marketing and Communications
More information about
Gómez-Acebo & Pombo
¡NEW! 
PUBLICATION
One week ago
Automotive and Sustainable Mobility No. 27
Summary of legislative and jurisprudential developments relating to the automotive sector.
One week ago 
PUBLICATION
30 Jul, 2025
Absolute prohibitions on pharmacy advertising are contrary to EU law
In its judgment of 19 June 2025 (European Commission v Republic of Poland, C‑200/24, ECLI:EU:C:2025:459), the Court of Justice has held that the introduction by national legislation of a total prohibition on advertising for pharmacies infringes European Union law.
30 Jul, 2025
PUBLICATION
09 Jul, 2025
Once again on the obligations assumed by the signers of a "strong" comfort letter
09 Jul, 2025
PUBLICATION
02 Jul, 2025
Pharma & Healthcare No. 44
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
02 Jul, 2025
PUBLICATION
19 Jun, 2025
Company resolutions reached with invalid votes
Although Article 204(3)(d) places them on the same level, the erroneous counting of votes and the counting of invalid votes are very different, given that the latter requires judicial balancing.
19 Jun, 2025
PUBLICATION
12 May, 2025
Automotive and Sustainable Mobility No. 26
Summary of legislative and case law developments in the automotive sector.
12 May, 2025
PUBLICATION
16 Apr, 2025
Pharma & Healthcare No. 43
The newsletter covers the main developments in Pharma & Healthcare legislation and case law.
16 Apr, 2025
PUBLICATION
27 Mar, 2025
The notion of ‘pharmacological action’ in the legal concept of medicinal product
A look at the judgment of the Court of Justice in Case C-589/23, Cassella-med and MCM Klosterfrau, ECLI:EU:C:2025:173.
27 Mar, 2025
PUBLICATION
25 Mar, 2025
A first ranking mortgage does not prevent a creditor from accelerating loan maturity due to debtor insolvency
If the creditor has a secured claim (even if the debt is covered by the "value of the security", i.e. the claim is in the money), the debtor cannot avoid the effects of the to-term forfeiture by appealing to the existence of that security because the guarantee referred to in Article 1129(1) of the Civil Code (avoiding to-term forfeiture) must then be another additional guarantee.
25 Mar, 2025